ONCOSYNE AS
Developing cancer treatments using patient-derived 3D tumoroid models.
Översikt
- 6
- Anställda
- 4.4milj NOK
- Omsättning
- 2020
- Grundat
Nyckelbeslutsfattare
Jarle Bruun
CEO and Co-founder
Peter W. Eide
CTO and Co-founder
Aarti Kapoor
Strategic Partnerships Director
Janne Nestvold
Business Advisor
+8 fler kontakter i Funnelfeedr
Beskrivning
Oncosyne operates at the forefront of precision oncology, utilizing its proprietary iCAN tumoroid platform. This platform creates living, patient-derived 3D tumor models that accurately mimic the characteristics of a patient's original cancer. For the pharmaceutical industry, Oncosyne offers compreh...